U.S. flag

An official website of the United States government

Display Settings:

Items per page

PMC Full-Text Search Results

Items: 16

1.
4.1

4.1. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 4 Interventions directed at healthcare providers, Outcome 1 Abstinence from smoking.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
2.
4.3

4.3. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 4 Interventions directed at healthcare providers, Outcome 3 Use of behavioural interventions.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
3.
1

1. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
4.
1.1

1.1. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 1 Interventions directed at individuals: abstinence from smoking, Outcome 1 Full versus no financial coverage.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
5.
1.3

1.3. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 1 Interventions directed at individuals: abstinence from smoking, Outcome 3 Partial versus no financial coverage.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
6.
2

2. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Prisma study flow diagram of studies included in most recent update of this review

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
7.
1.2

1.2. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 1 Interventions directed at individuals: abstinence from smoking, Outcome 2 Full versus partial financial coverage.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
8.
4.2

4.2. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 4 Interventions directed at healthcare providers, Outcome 2 Use of nicotine replacement therapy and/or bupropion.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
9.
3.3

3.3. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 3 Interventions directed at individuals: use of smoking cessation treatment, Outcome 3 Partial versus no financial coverage.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
10.
3.4

3.4. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 3 Interventions directed at individuals: use of smoking cessation treatment, Outcome 4 Partial versus partial financial coverage.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
11.
3.1

3.1. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 3 Interventions directed at individuals: use of smoking cessation treatment, Outcome 1 Full versus no financial coverage.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
12.
3.2

3.2. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 3 Interventions directed at individuals: use of smoking cessation treatment, Outcome 2 Full versus partial financial coverage.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
13.
1.4

1.4. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 1 Interventions directed at individuals: abstinence from smoking, Outcome 4 Partial versus another partial coverage (at least 6 months CA).

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
14.
2.3

2.3. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 2 Interventions directed at individuals: number of participants making a quit attempt for at least 24 h, Outcome 3 Partial versus no financial coverage.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
15.
2.2

2.2. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 2 Interventions directed at individuals: number of participants making a quit attempt for at least 24 h, Outcome 2 Full versus partial financial coverage.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.
16.
2.1

2.1. Analysis. From: Healthcare financing systems for increasing the use of tobacco dependence treatment.

Comparison 2 Interventions directed at individuals: number of participants making a quit attempt for at least 24 h, Outcome 1 Full versus no financial coverage.

Floor A van den Brand, et al. Cochrane Database Syst Rev. 2017 Sep;2017(9):CD004305.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center